Loading...
First Round of Abstract Submission Ends: Sep 30, 2026
Extended Early Bird Ends: Jan 28, 2026

Keynote Speakers

Prof. Monsef BENKIRANE
CNRS - Universite de Montpellier, France
Title: From mechanisms to cure: evolving: Perspectives on HIV-1 gene regulation and persistence.
Dr. Monsef Benkirane is a leading French virologist and former Director of the Institut de Génétique Humaine (CNRS/Université de Montpellier). His career spans over three decades of groundbreaking HIV research with profound impact on our understanding of viral gene transcription and in general RNA polymerase II-dependent transcription. Benkirane is best known for identifying SAMHD1 as a restriction factor blocking HIV-1 replication, a landmark discovery that fundamentally reshaped understanding of intrinsic immunity. His subsequent work illuminated HIV reservoir markers and chromatin-mediated immune evasion. An elected member of EMBO and the American Academy of Microbiology, Dr. Benkirane has received the CNRS Silver Medal, multiple ERC Advanced Grants, and the Liliane Bettencourt Prize.
Prof. Ronen Alon
Weizmann Institute of Science, Israel
Title: Lymphocyte Education in Tumor-Draining Lymph Nodes and Trafficking into Solid Tumors: Implications for Adoptive T Cell Therapies
Ronen Alon is a professor of Immunology at the Weizmann Institute of Science and a chair of the Department of Immunology and Regenerative Biology. His research explores the molecular mechanisms of leukocyte trafficking through blood vessels to target tissues in infection, inflammation and cancer. His group also studies how specific adhesion molecules mediate immune cell communications in specialized sites such as lymph nodes and solid tumors. He has also had long time interest in the roles of specific chemotactic cytokines, chemokines in leukocyte interactions with blood vessels and immune cells. Alon received his Ph.D. in biophysics and biochemistry from the Weizmann Institute in 1993, conducted a post doctoral research at Harvard University with Dr. Timothy Springer and joined the Weizmann Institute in 1996 where he became a full professor in 2009. Alon is a member of EMBO, was the president of the Israeli Immunological Society and has served in numerous academic, administrative and educational positions. He has published 200 research papers, reviews, and book chapters. Alon chaired the 2024 Gordon Conference on Chemotactic Cytokines in Maine U.S.A..
Prof. Rebecca Ingram
UK
Title: To be Confirmed
Will Update
Prof. Lachhman Das Singla
India
Title: Immunomodulation in Trypanosoma evansi Infections and Its Implications for Vaccine Responses in Livestock
Prof. L. D. Singla is an eminent veterinary parasitologist with extensive research contributions in host–parasite interactions, immunomodulation, and zoonotic diseases. His work has significantly advanced understanding of immunological responses in trypanosomosis and their implications for vaccine efficacy in livestock.
Prof. Zeliha Selamoglu
Nigde Ömer Halisdemir University, Turkey
Title: Will Update
Zeliha Selamoglu is a Full Professor in Medical Biology department of Nigde Ömer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 375 peerreviewed journal articles with over 8710 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals.
She is Top 2% Scientists Worldwide 2021, 2022, 2023, 2024, 2025 by Stanford University.
Highly Ranked Scholar for Prior Five Years: In the Traditional medicine in the top 0.05% of all scholars worldwide.
Dr. Maria Rosaria Galdiero
University of Naples Federico II, Italy
Title: Will Update
Will Update
Prof. Peter Aaby
Bandim Health Project
Title: Will Update
Will Update
Prof. Xi Yang
University of Manitoba, Canada
Title: Modulating effect of Sema3E on dendritic cell function
Dr. Xi Yang is a tenured Full Professor in the Department of Immunology with a cross-appointment in the Department of Medical Microbiology and Infectious Diseases at The University of Manitoba, Canada. He also served the Head of The Department of Immunology and the Canada Research Chair in Infection and Immunity. He received his medical degree (Medicine) and medical specialist degree (Nuclear Medicine) in Shandong University (Cheeloo Medical School) and Shanghai Jiaotong University (Shanghai Second Medical School), respectively. He then received his PhD in Immunology and postdoc training in Medical Microbiology and Infectious Diseases at the University of Manitoba. He became an Assistant Professor in the Department of Medical Microbiology and Infectious Diseases at the University of Manitoba with a cross-appointment in the Department of Immunology in 1997. He was promoted to Associate Professor with tenure in 2000 and Full Professor in 2005. He served as the Head of the Department of Immunology 2013-2019 at the University of Manitoba. His research focuses on the immune regulation mechanisms of allergy, infection and cancer, which have been supported continuously by multiple CIHR grants over the past three decades. He received his MRC fellowship in 1994, and his MRC Scholarship for junior faculty in 1997. He was awarded Canada Research Chair in Infection and Immunity by the Canadian government since 2002. He also received the Rh Award in Biological Sciences from the University of Manitoba and is included in Canadian Who’s Who since 2008. He was a former President of the Association of Chinese Professors in Manitoba. He has been serving as a panel member in numerous national and international research funding review panels including CIHR, CRC and NIH, and as editor/reviewer for multiple international scientific journals. He has published more than 140 research papers in various international journals.